Patient-centered care in MM involves aligning treatment with evolving quality-of-life priorities, especially during remission.

Expanding bispecific antibody access for multiple myeloma involves collaboration between academic centers and community ...

Multiple myeloma is a chronic (long-term) blood cancer that affects plasma cells made in the bone marrow, which is spongy tissue found inside bones. While people with multiple myeloma can live for ...

Patients with multiple myeloma are at significantly increased risk of venous thromboembolism (VTE), particularly in the first year after diagnosis. Numerous disease- and patient-related factors ...

Multiple myeloma is a rare blood cancer of the plasma cells in bone marrow -- the soft, spongy interior of bone where all blood cells are produced. Plasma cells are a type of white blood cell that ...

Patients share their unexpected journeys with multiple myeloma, revealing challenges and resilience in the face of a cancer ...

How Does Darzalex Faspro Work for Multiple Myeloma? Darzalex Faspro is a type of medicine called a monoclonal antibody that is also known as a targeted therapy or an immunotherapy. It works by ...

Estimates based on the most recent data from the NCI's Surveillance, Epidemiology, and End Results (SEER) program show that ...

Every year, an estimated 932 Filipinos are diagnosed with multiple myeloma, a cancer of the blood that develops in plasma cells found in the bone marrow. Plasma cells are a type of white blood cell ...

The National Comprehensive Cancer Network's Oncology Research Program selects projects to evaluate the effectiveness of elranatamab in the treatment of multiple myeloma. "Their research will help ...

Darzalex (daratumumab) is used for treating a blood cancer called multiple myeloma. Darzalex may be used to treat multiple myeloma that has never been treated, is relapsed, meaning the cancer came ...